Education
About Us
Working with TipRanks
Follow Us
Pharmesis International Ltd. (SG:BFK)
:BFK
BFK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.05 - $0.70
Previous CloseN/A
Volume1.00K
Average Volume (3M)806.00
Market Cap
$18.39M
Enterprise Value$20.41M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)12.8
Beta0.48
Next Earnings
Aug 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding31,700,000
10 Day Avg. Volume100
30 Day Avg. Volume806
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Pharmesis International Ltd. News
PremiumCompany Announcements
Pharmesis International Ltd. Returns to Profitability with New Herbal Segment
PremiumCompany Announcements
Pharmesis International Announces Secretary Changes
PremiumCompany Announcements
Pharmesis International Welcomes New Board Member
PremiumCompany Announcements
Pharmesis Announces Leadership Reshuffle---
BFK FAQ
What was Pharmesis International Ltd.’s price range in the past 12 months?
Pharmesis International Ltd. lowest share price was $0.05 and its highest was $0.70 in the past 12 months.
What is Pharmesis International Ltd.’s market cap?
Pharmesis International Ltd.’s market cap is $18.39M.
When is Pharmesis International Ltd.’s upcoming earnings report date?
Pharmesis International Ltd.’s upcoming earnings report date is Aug 18, 2025 which is in 111 days.
How were Pharmesis International Ltd.’s earnings last quarter?
Pharmesis International Ltd. released its earnings results on Feb 28, 2025. The company reported $0.068 earnings per share for the quarter, beating the consensus estimate of N/A by $0.068.
Is Pharmesis International Ltd. overvalued?
According to Wall Street analysts Pharmesis International Ltd.’s price is currently Overvalued.
Does Pharmesis International Ltd. pay dividends?
Pharmesis International Ltd. does not currently pay dividends.
What is Pharmesis International Ltd.’s EPS estimate?
Pharmesis International Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmesis International Ltd. have?
Pharmesis International Ltd. has 31,700,000 shares outstanding.
What happened to Pharmesis International Ltd.’s price movement after its last earnings report?
Pharmesis International Ltd. reported an EPS of $0.068 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pharmesis International Ltd.?
Currently, no hedge funds are holding shares in SG:BFK
---
Technical Analysis
Comfortdelgro
―
Jardine Cycle & Carriage
―
Singapore Land Group Limited
―
TalkMed Group Ltd.
―
Nera Telecommunications Ltd
―
---